Indian Pharma December 2014 Highlights

9
THE HEALTH OF INDIAN PHARMA MEDICINMAN Field Force excellence TM January 2015 | www.medicinman.net Since 2011 Jan-Dec 2014

Transcript of Indian Pharma December 2014 Highlights

Page 1: Indian Pharma December 2014 Highlights

THE HEALTH OF INDIAN PHARMA

MEDICINMANField Force excellence

TM

January 2015 | www.medicinman.net

Since 2011

Jan-Dec 2014

Page 2: Indian Pharma December 2014 Highlights

BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS

13th March 2015, Mumbai

FFE 2015FIELD FORCE EXCELLENCE

14th March 2015, Mumbai

PHARMA'S TWO MOST AWAITED EVENTS OF

2015 ARE HERE!Block the Dates: Fri, 13th & Sat, 14th March 2015 The Westin Hotel, Oberoi Garden City, Goregaon East,

Mumbai

Register Now!

Page 3: Indian Pharma December 2014 Highlights

BRANDST RM 2015BRAINSTORMING FOR PHARMA BRAND MANAGERS

MEDICINMAN

Kiran Khalap

Salil Kallianpur Amlesh Ranjan

Manish Bhagat

Susan Joshi

13th March 2015, Mumbai

Anup Soans

Key Topics at BrandStorm 2015

L How to launch and sustain brands in a VUCA world

L Harnessing digital & social media

L Patient-centric care

L Medical Affairs and KOL management

Target Audience: Product Managers, Group Product Managers, Marketing Managers & Digital Marketing teams

First announcement; detailed program schedule to follow

Page 4: Indian Pharma December 2014 Highlights

MEDICINMAN

FFE 2015FIELD FORCE EXCELLENCE

14th March 2015, Mumbai

CEO Breakfast

Shakti Chakraborty

Bhasker Iyer Sujay Shetty

Ganesh Nayak

Key Topics at FFE 2015The only pharma event in India with a CEO Roundtable on Field Force Excellence

L Managing the Millennial Field Force: Challenges & Opportunities

L Social Learning for Field Force - A viable option?

L Data Analytics: Can it provide actionable insights for segmented marketing?

Target Audience: Sales & Marketing Heads, SBU Heads, Senior Managers in HR, Training, SFE and other Field Force-related functions

First announcement; detailed program schedule to follow

Page 5: Indian Pharma December 2014 Highlights

REGISTRATION

Hosted by www.MedicinMan.net. Organized by Knowledge Media Venturz.

DELEGATE FEE* MATRIX FOR FFE 2015 & BRANDSTORM 2015

All figures in INR FFE BRANDSTORM BOTH

PHARMA DELEGATES 8,500/- 6,500/- 12,000/-

SERVICE PROVIDERS# 15,000/- 15,000/- 25,000/-

EARLY BIRD OFFER (BEFORE 20th January 2015)

PHARMA DELEGATES 7,500/- 5,500/- 10,000/-

SERVICE PROVIDERS# 12,500/- 12,500/- 20,000/-

To register, make payment and submit payment and delegate details by email to Chhaya Sankath ([email protected]) or register online: medicinman.net/2014/12/brandstorm-ffe-2015-registration

CHEQUE PAYMENT

Payment must be made in INR by Cheque / Bank Draft and must be received prior to the conference. Cheques to be issued in the name of “KNOWLEDGE MEDIA VENTURZ LLP”, payable at Mumbai.

SEND CHEQUES TO:Chhaya Sankath, A-302, Kshitij C. H. S. L., Off Film City Road, Behind Satellite Towers, Goregaon East, Mumbai 400 063

PAY BY ACCOUNT TRANSFERNEFT DETAILS BANK: AXIS BANK BRANCH: GOREGAON WEST, MUMBAI (MH), GR FLR, PATKAR COLLEGE, S V ROAD, GOREGAON WEST, MUMBAI -62. ACCOUNT NAME: KNOWLEDGE MEDIA VENTURZ LLPACCOUNT NO: 913020033732313 IFSC CODE: UTIB0000647

DELEGATE DETAILS (TO BE SENT ALONG WITH DETAILS OF PAYMENT)NAME:COMPANY:DESIGNATION:ADDRESS: EMAIL: MOBILE:DETAILS OF CHEQUE/ NEFT TRANSFER:

PAYMENT OPTIONS

*Add Service Tax @ 12.36% # Only 10 Service Provider passes available, on a first-come, first-serve basis

Page 6: Indian Pharma December 2014 Highlights

Market Data: Jan-Dec 2014

Key Insights for December 2014:

1. For Month of Dec -14, we have seen the GDs as 5.1% in Volumes, 5.3% in Price Increases & 3.2% in NIs against a 4.1% in volumes in Dec -13

2. Price Increases was at 5.3%, which has been the highest in the last 12 months in the IPM3. There has been a growth registered (10.3%) in this quarter which is higher than the

corresponding Quarter last year (4.3%)

Key Highlights for December 2014:

Key Numbers:1. The IPM clocked 7375 Crs in December 20142. The Indian Pharma Market grows at 13.6% for the month of December 2014

Corporate:1. For the month of December 2014, amongst the top 10, Ranbaxy grew by 28.7% followed

by Pfizer at 23.1% & Sun Pharma at 21.5%2. 21 corporate have crossed the growth of IPM for the month of December 2014 amongst

top 503. Amongst the top 50 Corporate, Akumentis has the highest growth of 69.4% followed by

Merck at 37.8% & Albert David at 32.0%4. 30 Corporate showed growths more than 10% amongst the top 505. Amongst the 11-20 ranked Corporate Torrent has the highest growth of 31.1% followed by

Macleods at 30.1% & USV at 24.9%

After the peak in Sep 2014, the market showed a dip due to festive season, however for last 2 months the market has be in a positive trend with Dec month at 13.6%

Source: AIOCD Pharmasofttech AWACS

The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN

Page 7: Indian Pharma December 2014 Highlights

6. Amongst the 51-60 ranked Corporate, Panacea grows at 42.0% followed by Pharmed at 17.7% & Systopic at 17.2%

7. Amongst the 61-75 ranked Corporate, Boehringer grew by 62.1% followed by Tablets India at 23.3% & Serdia at 18.8%

8. Ranbaxy enters the 3000 Cr Club, Panacea enters the 300 Cr Club as on MAT Dec 2014

Indian V/S MNCs:1. Indian companies have grown at 12.1% versus 17.5% for MNCs in December 20142. Amongst the top 50 in MNCs Merck grew by 37.8% followed by Ranbaxy at 28.7%, MSD

at 26.1% & Pfizer at 24.3%3. Under the Non-NLEM category Indian Companies grew at 13.6% whereas MNCs grew at

18.0%4. For the Dec Quarter the MNCs have shown a volume growth of 6.4% versus 1.0% for the

Indian companies5. DPCO V/s Non DPCO Market:6. The DPCO containing molecules market grew at 8.0 % whereas the non DPCO market

grew by 14.8% resulting in an overall growth of 13.6% for December 20147. NLEM & Non - NLEM Category showed unit growth at 0.7% and 3.2% respectively8. The DPCO 2013 portfolio for Pfizer grew at 13.9%, GSK 1.7%, Ranbaxy 41.9%

December 2014Val in Cr Units in 000s

Value Growth Unit GrowthIPM 7,357 13.6% 1,579,638 2.7%NLEM 1,252 8.0% 320,126 0.7%Non-NLEM 6,123 14.8% 1,259,512 3.2%

Source: AIOCD Pharmasofttech AWACS

The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN

Page 8: Indian Pharma December 2014 Highlights

Therapy:1. From therapy perspective 4 therapies have outgrown the IPM growth & 14 therapies have

double digit growths2. Respiratory Market grew at 10.0%, Gastrointestinal market grew at 13.5% , Pain &

Analgesics market grew at 11.3% whereas Anti-infectives grew at 5.2%3. Anti-diabetic market grows at 33.1% & Cardiac at 18.2% in chronic business4. Derma market grew by 19.6% & Urology Market at 29.7% Regional Dynamics:1. From regional perspective 11 regions have outgrown the IPM growth2. Mumbai market grew the highest at 21.9% followed by Gujarat market at 21.7% & Kerala

Market at 20.7%3. No regions had negative growth in December 2014

Molecules:1. Amoxycillin + Clavulanic Acid Market grew at 8.2% whereas Glimepiride + Metformin

grows at 20.0% at No 2.2. The markets of Paracetamol grew at 5.6%, Atorvastatin 24.0%, Probiotic Microbes at

26.9%, Cefixime 1.1%, Pantoprazole 15.3%, Montelukast + Levocetrizine at 20.4%, Glimepiride + Metformin + Pioglitazone at 28.1%, Vitamin-D at 29.4%, Hydroquinone + Mometasone + Tretinoin at 34.7%, Voglibose + Metformin + Glimepiride at 57.0%, Leveteracetam at 37.2%, Protein Supplements at 24.1%

Brands:1. Mixtard continues to lead the pack with 41.7 Crs for the Month of Dec -14 with a growth

of 47.8%2. Mixtard grew at 47.8%, Lantus grew at 36.7% & Glycomet- GP grows at 36.3%, Augmentin

grows at 16.2%, amongst the top 10 Brands3. Amongst the Brands who have gained ranks include Clexane (+64), Janumet (+54),

Januvia (+43), Shelcal (+38), Panderm Plus (+31), Istamet (+29), Rosuvas & Jalra (+26), Novomix, Susten & Jalra-M (+17), Taxim, Pan & Levipil (+15), Zincovit (+13), Dexorange, Orofer-XT & Tonact (+9), Liv -52(+6), amongst Top 100 Brands over December 13

New Launches in IPM:1. Total 361 SKUs & 185 Brands launched in December 20142. Top New Brands for December are Biovac V, Ryzodeg & Canmab3. 2 New Subgroups got launched as Roflumilast & Cyclobenzaparine + Diclofenac

Source: AIOCD Pharmasofttech AWACS

The Health of Indian Pharma: Jan-Dec 2014MEDICINMAN

Page 9: Indian Pharma December 2014 Highlights

CAREER PROGRESSION RESOURCES

NOW AVAILABLE ON

(click on the books to purchase on flipkart)

SuperVision for the SuperWiser Front-line Manager is a tool to help pharma professionals transition from super salesmen to great front-line managers and leaders. The book will equip front-line managers to Manage, Coach, Motivate and Lead their teams to deliver outstanding performance. An engaging read, filled with examples and illustrations, SuperVision for the SuperWiser Front-line Manager has been used by thousands of managers across the industry.

HardKnocks for the GreenHorn is a specially crafted training manual to enable Medical Representatives to gain the Knowledge, Skills and Attitude needed to succeed in the competitive arena of pharma field sales. Medical Representatives joining the field are often not aware about the key success factors of their job and as a result they get discouraged when things don’t go as planned. HardKnocks for the GreenHorn is a powerful learning and motivational tool for field sales managers to build their sales teams.

RS 799 699/-(Limited period offer. Till stocks last)

RS 599 499/-(Limited period offer. Till stocks last)